[{"path":"https://openpharma.github.io/savvyr/authors.html","id":null,"dir":"","previous_headings":"","what":"Authors","title":"Authors and Citation","text":"Thomas Kuenzel. Author, maintainer. Kaspar Rufibach. Author. Regina Stegherr. Author. Daniel Sabanes Bove. Author. F. Hoffmann-La Roche AG. Copyright holder, funder. Universität Ulm. Copyright holder, funder.","code":""},{"path":"https://openpharma.github.io/savvyr/authors.html","id":"citation","dir":"","previous_headings":"","what":"Citation","title":"Authors and Citation","text":"Kuenzel T, Rufibach K, Stegherr R, Sabanes Bove D (2024). savvyr: Survival Analysis AdVerse Events VarYing Follow-Times R. R package version 0.1.0, https://github.com/openpharma/savvyr/.","code":"@Manual{,   title = {savvyr: Survival Analysis for AdVerse Events with VarYing Follow-Up Times in R},   author = {Thomas Kuenzel and Kaspar Rufibach and Regina Stegherr and Daniel {Sabanes Bove}},   year = {2024},   note = {R package version 0.1.0},   url = {https://github.com/openpharma/savvyr/}, }"},{"path":"https://openpharma.github.io/savvyr/index.html","id":"savvyr","dir":"","previous_headings":"","what":"Survival Analysis for AdVerse Events with VarYing Follow-Up Times in R","title":"Survival Analysis for AdVerse Events with VarYing Follow-Up Times in R","text":"Short description package","code":""},{"path":"https://openpharma.github.io/savvyr/reference/aalen_johansen.html","id":null,"dir":"Reference","previous_headings":"","what":"Aalen Johansen Estimator — aalen_johansen","title":"Aalen Johansen Estimator — aalen_johansen","text":"function calculates Aalen Johansen estimator adverse events  observed [0, tau]. Please also refer  Stegherr et al. (2021) .","code":""},{"path":"https://openpharma.github.io/savvyr/reference/aalen_johansen.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Aalen Johansen Estimator — aalen_johansen","text":"","code":"aalen_johansen(data, ce, tau)"},{"path":"https://openpharma.github.io/savvyr/reference/aalen_johansen.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Aalen Johansen Estimator — aalen_johansen","text":"data (data.frame) columns including time_to_event: Time first AE, death soft competing event. type_of_event: 0 censored, 1 AE, 2 death, 3 soft competing event. ce (number) code competing event. tau (number) milestone Aalen-Johansen computed.","code":""},{"path":"https://openpharma.github.io/savvyr/reference/aalen_johansen.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Aalen Johansen Estimator — aalen_johansen","text":"(vector) following entries: ae_prob: Estimated probability AE. ae_prob_var: Variance estimate. ce_prob: Estimated probability competing events. ce_prob_var: Variance competing events.","code":""},{"path":"https://openpharma.github.io/savvyr/reference/aalen_johansen.html","id":"references","dir":"Reference","previous_headings":"","what":"References","title":"Aalen Johansen Estimator — aalen_johansen","text":"Stegherr R, Schmoor C, Lübbert M, Friede T, Beyersmann J (2021). “Estimating comparing adverse event probabilities presence varying follow-times competing events.” Pharmaceutical Statistics, 20(6), 1125--1146. doi:10.1002/pst.2130 , https://onlinelibrary.wiley.com/doi/abs/10.1002/pst.2130.","code":""},{"path":"https://openpharma.github.io/savvyr/reference/aalen_johansen.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Aalen Johansen Estimator — aalen_johansen","text":"","code":"set.seed(123) dat <- generate_data(n = 5, cens = c(2, 5), haz_ae = 2, haz_death = 3, haz_soft = 5) aalen_johansen(dat, ce = 2, tau = 4) #>     ae_prob ae_prob_var     ce_prob ce_prob_var  #>       0.200       0.032       0.800       0.032"},{"path":"https://openpharma.github.io/savvyr/reference/generate_data.html","id":null,"dir":"Reference","previous_headings":"","what":"Generate Example Data — generate_data","title":"Generate Example Data — generate_data","text":"generates dataset denoted S1 Table 4 Stegherr et al. (2021) , .e. assume constant hazards adverse event (AE) hazard, hazard competing event death, hazard \"soft\" competing events. Censoring uniform given range.","code":""},{"path":"https://openpharma.github.io/savvyr/reference/generate_data.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Generate Example Data — generate_data","text":"","code":"generate_data(n, cens, haz_ae, haz_death, haz_soft)"},{"path":"https://openpharma.github.io/savvyr/reference/generate_data.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Generate Example Data — generate_data","text":"n (count) number patients. cens (numeric) minimum maximum censoring time. haz_ae (number) constant hazard AE. haz_death (number) constant hazard death. haz_soft (number) constant hazard soft competing event.","code":""},{"path":"https://openpharma.github.io/savvyr/reference/generate_data.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Generate Example Data — generate_data","text":"(data.frame) data.frame following columns: id: Patient ID. time_to_event: Time first AE, death soft competing event. type_of_event: 0 censored, 1 AE, 2 death, 3 soft competing event. cens: Censoring time.","code":""},{"path":"https://openpharma.github.io/savvyr/reference/generate_data.html","id":"references","dir":"Reference","previous_headings":"","what":"References","title":"Generate Example Data — generate_data","text":"Stegherr R, Schmoor C, Lübbert M, Friede T, Beyersmann J (2021). “Estimating comparing adverse event probabilities presence varying follow-times competing events.” Pharmaceutical Statistics, 20(6), 1125--1146. doi:10.1002/pst.2130 , https://onlinelibrary.wiley.com/doi/abs/10.1002/pst.2130.","code":""},{"path":"https://openpharma.github.io/savvyr/reference/generate_data.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Generate Example Data — generate_data","text":"","code":"set.seed(123) generate_data(n = 5, cens = c(2, 5), haz_ae = 2, haz_death = 3, haz_soft = 5) #>   id time_to_event type_of_event     cens #> 1  1   0.084345726             2 4.032712 #> 2  2   0.057661027             2 3.717900 #> 3  3   0.132905487             2 2.308774 #> 4  4   0.003157736             2 4.699475 #> 5  5   0.005621098             1 2.738263"},{"path":"https://openpharma.github.io/savvyr/reference/inc_prop.html","id":null,"dir":"Reference","previous_headings":"","what":"Computing the Incidence Proportion — inc_prop","title":"Computing the Incidence Proportion — inc_prop","text":"Computing Incidence Proportion","code":""},{"path":"https://openpharma.github.io/savvyr/reference/inc_prop.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Computing the Incidence Proportion — inc_prop","text":"","code":"inc_prop(data, tau)"},{"path":"https://openpharma.github.io/savvyr/reference/inc_prop.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Computing the Incidence Proportion — inc_prop","text":"data (data.frame) columns including: time_to_event: Time first AE, death soft competing event. type_of_event: 0 censored, 1 AE, 2 death, 3 soft competing event. tau (numeric) milestone incidence proportion computed.","code":""},{"path":"https://openpharma.github.io/savvyr/reference/inc_prop.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Computing the Incidence Proportion — inc_prop","text":"(vector) following entries: ae_prob: Estimated probability AE. ae_prob_var: Variance estimate.","code":""},{"path":"https://openpharma.github.io/savvyr/reference/inc_prop.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Computing the Incidence Proportion — inc_prop","text":"","code":"set.seed(123) dat <- generate_data(   n = 5,   cens = c(2, 5),   haz_ae = 2,   haz_death = 3,   haz_soft = 5 )  inc_prop(dat, tau = 4) #>     ae_prob ae_prob_var  #>       0.200       0.032"},{"path":"https://openpharma.github.io/savvyr/reference/one_minus_kaplan_meier.html","id":null,"dir":"Reference","previous_headings":"","what":"One Minus Kaplan-Meier — one_minus_kaplan_meier","title":"One Minus Kaplan-Meier — one_minus_kaplan_meier","text":"function calculates one minus Kaplan-Meier estimator adverse events (censoring competing events) observed [0, tau]. Please also refer formula (4) Stegherr et al. (2021) .","code":""},{"path":"https://openpharma.github.io/savvyr/reference/one_minus_kaplan_meier.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"One Minus Kaplan-Meier — one_minus_kaplan_meier","text":"","code":"one_minus_kaplan_meier(data, tau)"},{"path":"https://openpharma.github.io/savvyr/reference/one_minus_kaplan_meier.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"One Minus Kaplan-Meier — one_minus_kaplan_meier","text":"data (data.frame) columns including time_to_event: Time first AE, death soft competing event. type_of_event: 0 censored, 1 AE, 2 death, 3 soft competing event. tau (number) milestone One Minus Kaplan-Meier computed.","code":""},{"path":"https://openpharma.github.io/savvyr/reference/one_minus_kaplan_meier.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"One Minus Kaplan-Meier — one_minus_kaplan_meier","text":"(vector) following entries: ae_prob: Estimated probability AE. ae_prob_var: Variance estimate.","code":""},{"path":"https://openpharma.github.io/savvyr/reference/one_minus_kaplan_meier.html","id":"references","dir":"Reference","previous_headings":"","what":"References","title":"One Minus Kaplan-Meier — one_minus_kaplan_meier","text":"Stegherr R, Beyersmann J, Jehl V, Rufibach K, Leverkus F, Schmoor C, Friede T (2021). “Survival analysis AdVerse events VarYing follow-times (SAVVY): Rationale statistical concept meta-analytic study.” Biometrical Journal, 63(3), 650-670. doi:10.1002/bimj.201900347 , https://onlinelibrary.wiley.com/doi/pdf/10.1002/bimj.201900347, https://onlinelibrary.wiley.com/doi/abs/10.1002/bimj.201900347.","code":""},{"path":"https://openpharma.github.io/savvyr/reference/one_minus_kaplan_meier.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"One Minus Kaplan-Meier — one_minus_kaplan_meier","text":"","code":"set.seed(123) dat <- generate_data(n = 5, cens = c(2, 5), haz_ae = 2, haz_death = 3, haz_soft = 5) one_minus_kaplan_meier(dat, tau = 4) #>     ae_prob ae_prob_var  #>    0.250000    0.046875"},{"path":"https://openpharma.github.io/savvyr/reference/prop_trans_inc_dens.html","id":null,"dir":"Reference","previous_headings":"","what":"Computing the Probability Transform Incidence Density — prop_trans_inc_dens","title":"Computing the Probability Transform Incidence Density — prop_trans_inc_dens","text":"Computing Probability Transform Incidence Density","code":""},{"path":"https://openpharma.github.io/savvyr/reference/prop_trans_inc_dens.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Computing the Probability Transform Incidence Density — prop_trans_inc_dens","text":"","code":"prop_trans_inc_dens(data, tau)"},{"path":"https://openpharma.github.io/savvyr/reference/prop_trans_inc_dens.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Computing the Probability Transform Incidence Density — prop_trans_inc_dens","text":"data (data.frame) columns including time_to_event: Time first AE, death soft competing event. type_of_event: 0 censored, 1 AE, 2 death, 3 soft competing event. tau (number) milestone Probability Transform Incidence Density computed.","code":""},{"path":"https://openpharma.github.io/savvyr/reference/prop_trans_inc_dens.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Computing the Probability Transform Incidence Density — prop_trans_inc_dens","text":"(vector) following entries: ae_prob: Estimated probability AE. ae_prob_var: Variance estimate.","code":""},{"path":"https://openpharma.github.io/savvyr/reference/prop_trans_inc_dens.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Computing the Probability Transform Incidence Density — prop_trans_inc_dens","text":"","code":"set.seed(123) dat <- generate_data(n = 5, cens = c(2, 5), haz_ae = 2, haz_death = 3, haz_soft = 5) prop_trans_inc_dens(dat, tau = 4) #>      ae_prob  ae_prob_var  #> 9.999992e-01 1.125795e-10"},{"path":"https://openpharma.github.io/savvyr/reference/prop_trans_inc_dens_ce.html","id":null,"dir":"Reference","previous_headings":"","what":"Probability Transform Incidence Density Accounting for Competing Events — prop_trans_inc_dens_ce","title":"Probability Transform Incidence Density Accounting for Competing Events — prop_trans_inc_dens_ce","text":"function calculates incidence density adverse events specified competing events observed [0, tau] combines transforms incidence densities probability scale. Please also refer formulas (4) (5) Stegherr et al. (2021) .","code":""},{"path":"https://openpharma.github.io/savvyr/reference/prop_trans_inc_dens_ce.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Probability Transform Incidence Density Accounting for Competing Events — prop_trans_inc_dens_ce","text":"","code":"prop_trans_inc_dens_ce(data, ce, tau)"},{"path":"https://openpharma.github.io/savvyr/reference/prop_trans_inc_dens_ce.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Probability Transform Incidence Density Accounting for Competing Events — prop_trans_inc_dens_ce","text":"data (data.frame) columns including time_to_event: Time first AE, death soft competing event. type_of_event: 0 censored, 1 AE, 2 death, 3 soft competing event. ce (number) code competing event. tau (number) milestone Probability Transform Incidence Density computed.","code":""},{"path":"https://openpharma.github.io/savvyr/reference/prop_trans_inc_dens_ce.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Probability Transform Incidence Density Accounting for Competing Events — prop_trans_inc_dens_ce","text":"(vector) following entries: ae_prob: Estimated probability AE. ae_prob_var: Variance estimate.","code":""},{"path":"https://openpharma.github.io/savvyr/reference/prop_trans_inc_dens_ce.html","id":"references","dir":"Reference","previous_headings":"","what":"References","title":"Probability Transform Incidence Density Accounting for Competing Events — prop_trans_inc_dens_ce","text":"Stegherr R, Schmoor C, Beyersmann J, Rufibach K, Jehl V, Brückner , Eisele L, Künzel T, Kupas K, Langer F, Leverkus F, Loos , Norenberg C, Voss F, Friede T (2021). “Survival analysis AdVerse events VarYing follow-times (SAVVY)—estimation adverse event risks.” Trials, 22(1), 420. ISSN 1745-6215, doi:10.1186/s13063-021-05354-x .","code":""},{"path":"https://openpharma.github.io/savvyr/reference/prop_trans_inc_dens_ce.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Probability Transform Incidence Density Accounting for Competing Events — prop_trans_inc_dens_ce","text":"","code":"set.seed(123) dat <- generate_data(n = 5, cens = c(2, 5), haz_ae = 2, haz_death = 3, haz_soft = 5) prop_trans_inc_dens_ce(dat, ce = 2, tau = 4) #>     ae_prob ae_prob_var  #>       0.200       0.032"},{"path":"https://openpharma.github.io/savvyr/reference/savvyr-package.html","id":null,"dir":"Reference","previous_headings":"","what":"savvyr: Survival Analysis for AdVerse Events with VarYing Follow-Up Times in R — savvyr-package","title":"savvyr: Survival Analysis for AdVerse Events with VarYing Follow-Up Times in R — savvyr-package","text":"SAVVY project consortium academic pharmaceutical industry partners aims improve analyses adverse event (AE) data clinical trials use survival techniques appropriately dealing varying follow-times competing events. Although statistical methodologies advanced, AE analyses often incidence proportion, incidence density non-parametric Kaplan-Meier estimator used, either ignore censoring competing events. package contains functions easily conduct proposed improved AE analyses.","code":""},{"path":[]},{"path":"https://openpharma.github.io/savvyr/reference/savvyr-package.html","id":"author","dir":"Reference","previous_headings":"","what":"Author","title":"savvyr: Survival Analysis for AdVerse Events with VarYing Follow-Up Times in R — savvyr-package","text":"Maintainer: Thomas Kuenzel thomas.kuenzel@roche.com Authors: Kaspar Rufibach kaspar.rufibach@roche.com Regina Stegherr regina.stegherr@uni-ulm.de Daniel Sabanes Bove daniel.sabanes_bove@roche.com contributors: F. Hoffmann-La Roche AG [copyright holder, funder] Universität Ulm [copyright holder, funder]","code":""},{"path":[]},{"path":"https://openpharma.github.io/savvyr/news/index.html","id":"new-features-0-1-0","dir":"Changelog","previous_headings":"","what":"New features","title":"savvyr 0.1.0","text":"Add initializer script.","code":""},{"path":"https://openpharma.github.io/savvyr/news/index.html","id":"enhancements-0-1-0","dir":"Changelog","previous_headings":"","what":"Enhancements","title":"savvyr 0.1.0","text":"Documentation use initialize package.","code":""},{"path":"https://openpharma.github.io/savvyr/news/index.html","id":"bug-fixes-0-1-0","dir":"Changelog","previous_headings":"","what":"Bug fixes","title":"savvyr 0.1.0","text":"None.","code":""}]
